###### Article summary

Article focus
=============

-   Some studies have reported lower error rates with more senior prescriber grades, and insufficient undergraduate prescriber training as a potential risk for prescribing errors.

-   Prescriptions frequently contain multiple medications, but data about errors on complete prescriptions (all prescribed items on an inpatient chart or discharge prescription), which give a better estimate of numbers of patients at risk of harm, are lacking.

-   We aimed to determine the differences in prescribing error rates between grades of prescriber, ward area, admission or discharge and type of medication prescribed.

Key messages
============

-   We observed an error rate of 10.9% per prescribed item, with only 56.2% of 4238 complete prescriptions remaining error free.

-   In multivariate analysis, the strongest predictor for prescribing error was the number of medicines on each prescription.

-   We found no overall difference in error rate among different grades of prescriber, and newly qualified doctors were not more likely to make errors than their senior colleagues.

Strengths and limitations of this study
=======================================

-   This was a large study across nine diverse hospital settings.

-   We determined the rate of errors on complete prescriptions as well as for individually prescribed items, giving a better estimate of the numbers of patients affected by errors.

-   We did not evaluate the impact of electronic prescribing on the prevalence and type of prescribing errors; however, up to a quarter of the errors observed could potentially have been avoided through use of electronic prescribing and medicine administration systems.

Introduction {#s1}
============

Prescribing errors are common, with systematic reviews suggesting that as many as 50% of hospital admissions and 7% of medication orders are affected.[@R1] In recent studies, prescribing errors have been found to affect approximately 9--15% of medication orders for hospital inpatients in the UK.[@R2] [@R3] Over one-third of 651 patients were found to have a prescribing error occurring at hospital admission in the USA.[@R4] Prescribing errors are also prevalent in primary care, affecting 37% of 9385 prescriptions in the USA,[@R5] and one in eight patients (1 in 20 prescription items) in the UK.[@R6] A study in the Netherlands evaluating medication omission errors in elderly patients admitted to hospital reported adverse consequences in 21% of 100 patients.[@R7]

Human error in healthcare may be considered in the context of individuals or health systems.[@R8; @R9; @R10] While personal factors such as forgetfulness, inattention, poor motivation, carelessness, negligence and recklessness are important, a health systems approach more comprehensively addresses recurrent errors and organisation factors and processes which may give rise to that error. The person, the team, the task, the workplace and the institution as a whole are considered,[@R8] which identify weaknesses in the system\'s defences.[@R8] For example, higher hospital mortality at weekends may be associated with lower numbers of senior staff available outside of the normal working week.[@R11] [@R12] Barriers which may prevent medication errors, or prevent errors from reaching the patient, may include electronic prescribing alerts, and prescription review by clinical pharmacists.

Data on factors which may contribute to prescribing errors, for example, differences between grades of prescriber, ward area, admission or discharge and type of medication prescribed are sparse.[@R3] [@R13] [@R14] Existing data suggest that newly qualified and junior doctors are twice as likely to make prescribing errors than senior doctors, taking into account the larger volume of prescriptions written by junior prescriber grades.[@R3] Provision of sufficient undergraduate training to allow medical students to become safe prescribers when they begin work as newly qualified doctors is widely recognised as an important factor in reducing prescribing errors.[@R13] [@R15; @R16; @R17] Teaching in the UK medical schools has changed considerably over the last decade, with the General Medical Council stipulating that medical students must be adequately prepared to prescribe drugs and manage risk at the point of graduation.[@R18] [@R19]

While previous studies have evaluated error for individual medications, few studies have systematically evaluated complete prescriptions (all items included on a single inpatient prescription chart or discharge prescription at the time of clinical pharmacist check) to evaluate factors associated with prescribing error.[@R1; @R2; @R3] This is important as it gives a more accurate estimate of the numbers of patients who are potentially put at risk of harm by prescribing errors. We undertook a prospective survey of prescribing errors in nine diverse National Health Service (NHS) hospitals in the North West of England, aiming to examine the differences in prescribing error rates between grades of prescriber, ward area, admission or discharge, hospitals and the type and number of medicines prescribed. In order to further evaluate the role of undergraduate training, we also tested for a relationship between occurrence of error and medical school training of prescribers. As approximately 30% of the prescribers were trained at the local institution, the University of Liverpool, whether medical training was undertaken at this institution was included in the analysis. Univariate analysis and multivariate logistic regression was used to evaluate factors associated with prescribing errors.

Methods {#s2}
=======

Setting {#s2a}
-------

A total of nine NHS hospitals from the Merseyside and Cheshire region took part in the audit. These comprised large teaching hospitals, general hospitals, specialist centres for paediatrics, women\'s health and mental health ([table 1](#BMJOPEN2012002036TB1){ref-type="table"}). One hospital was using complete electronic prescribing systems (inpatient prescribing, medication ordering, discharge prescriptions) on some wards at the time of the audit. Eight of the hospitals were using paper prescription charts for inpatients and either handwritten or transcribed electronically generated discharge prescriptions. In this setting, ward-based clinical pharmacists check inpatient prescriptions at, or soon after patient admission, when medicines reconciliation is undertaken. Inpatient prescription charts are then checked at least daily by the pharmacist. Discharge prescriptions are checked and authorised by a clinical pharmacist prior to supply of medication. Pharmacists may amend or clarify some aspects of prescribing, or discuss with the clinical team any recommendations or safety issues at these points of care. Clinical pharmacists may also participate in ward rounds and multidisciplinary team meetings, where prescribing may be discussed with clinicians, clarified or amended.

###### 

Types of hospitals contributing prescription data

  Teaching hospitals   District hospitals   Specialist hospitals (women, paediatrics,mental health)
  -------------------- -------------------- ---------------------------------------------------------
  Hospital A           Hospital B           Hospital D
  Hospital C           Hospital E           Hospital G
  Hospital H           Hospital F           Hospital I

Data collection {#s2b}
---------------

As this was an audit of unlinked anonymised prescriptions, Ethics approval was not required in accordance with local guidance. We aimed to capture data from all seven hospital trusts in the region. Two additional hospitals adjacent to and linked with healthcare provision in the Merseyside region were also audited. The number of prescriptions audited was empirically determined in order to generate a sample size equivalent to a large study recently undertaken in the UK. In order to audit practice across the region, each hospital was asked to audit a minimum of 400 prescriptions.

We adopted the following definition of prescribing errors for the study, which excludes adherence to local prescribing policy and guidelines 'A clinically meaningful prescribing error occurs when, as a result of a prescribing decision or prescription writing process, there is an unintentional significant: (1) reduction in the probability of treatment being timely and effective or (2) increase in the risk of harm when compared with generally accepted practice'.[@R20] A standard questionnaire collected data on error category and severity (based on EQUIP error classifications). The EQUIP study was a large prospective survey of prescribing errors affecting hospital inpatients in the UK, and the error classifications were therefore considered relevant to our setting. Nominated ward-based clinical pharmacists prospectively documented prescribing errors at the point of checking inpatient or discharge prescriptions, during normal pharmacy working hours, therefore each audit form was a point prevalence of prescribing errors at the time of pharmacist clinical check. Acute admission was defined as the first 24 h in hospital. For all prescription sheets generated in acute admission settings, a separate audit form was completed (to allow for emergency prescribing in the absence of a full drug history without this being recorded as an error) and we sought to record only unintended medication omissions (eg, following medicines reconciliation with general practices or primary healthcare databases). Hospitals were advised to complete the study on different days of the week throughout the period of the audit, in order to capture an even spread of days. For example data collection would occur weekly, on Monday in week one, Tuesday in week two, Wednesday in week three, in order to minimise double auditing of the same patient on admission to hospital and subsequent admission to a ward. Therefore, if patients were audited twice, an interval of at least 1 week would separate each audit form, unless their acute admission/inpatient/discharge prescriptions were audited on the same day. If items on prescriptions had been previously screened, they would be counted again in any subsequent auditing, though there would be a 1-week interval since previous auditing, or the patient would be a different stage of hospital admission. All types of medication order were audited, including intravenous fluids, when required and once only medication.

Prescriber category {#s2c}
-------------------

Pharmacists were required to indicate the category of prescribers on data collection forms. For this analysis, prescribers were categorised as follows: newly qualified (foundation year 1, house officers), junior (foundation year 2, specialist or 'core' training years 1 and 2), mid-grade (specialist registrars, training fellows), senior (consultant), non-medical (nurse or pharmacist prescribers), other (eg, locum doctors for whom grade was unclear) and unknown (no information concerning prescriber recorded).

Grading of prescribing errors {#s2d}
-----------------------------

We modified EQUIP study criteria[@R3] for error categorisation and severity classification by adding or clarifying severity criteria for all error categories, and by grouping errors into 10 distinct areas according to stage of the prescribing process (see below and [table 2](#BMJOPEN2012002036TB2){ref-type="table"}). 'Exclusion' and 'inclusion' of errors into EQUIP study error types were defined, in order to differentiate categories with potential overlap. Severity ratings were further defined and assigned to each error category based on modified EQUIP study criteria and taking into account the perceptions of the original pharmacist gradings. Severity ratings related to the potential severity, had the error been allowed to progress through to the patient, as the majority of errors were corrected prior to the point of administration. In order to limit misclassification of errors, the original 29 EQUIP categories were batched into 10 different types of error groups as follows: (1) Dosing errors, (2) Writing errors, (3) Allergy status errors, (4) Duration of treatment wrong/not specified, (5) Drug interactions, (6) Omission of medication, (7) Excessive/unnecessary prescribing, (8) Clinical safety errors, (9) Lack of clear directions for administration and (10) a new error category (Miscellaneous) was added ([table 2](#BMJOPEN2012002036TB2){ref-type="table"}). The modification and definition of error categories and severities were undertaken by two members of the study team (KS and SK) and agreed by a third (TK).

###### 

Application of error categories and severity ratings for the Mersey Deanery Prescribing Audit

  Modified EQUIP error category                     Original EQUIP error category                    Includes/excludes                                                                                                                                                                     Severity (EQUIP)                                                                                                                                                                                                                                                                                                                                       Severity modification
  ------------------------------------------------- ------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1\. Dosing Errors                                 Underdose                                                                                                                                                                                                                              *Minor* if unable/unlikely to carry out (units); *Significant* if dose too low to treat the condition; *Serious* if patient in acute distress; *Potentially Lethal* if medication life saving                                                                                                                                                          
                                                    Overdose                                         Excludes overdoses caused by duplication eg, Paracetamol with co-codamol                                                                                                              *Minor* if unable/unlikely to carry out (units); *Significant*---low TI, ½-4 times; *Serious*- Low TI, 4-10 times; errors in units if chance dose could be given; *Potentially Lethal* if very low TI and dose 10 times normal dose, results in serum levels of drug in severe toxicity range, or has high potential to cause cardiopulmonary arrest   *Minor* if effect of dosing expected to be minimal
                                                    Dose/rate mismatch                                                                                                                                                                                                                     --                                                                                                                                                                                                                                                                                                                                                     Judgement used based on Equip severity categories
  2\. Writing errors                                Strength/dose missing                            Includes dose units missing                                                                                                                                                           *Minor*                                                                                                                                                                                                                                                                                                                                                
                                                    Product/formulation not specified                                                                                                                                                                                                      --                                                                                                                                                                                                                                                                                                                                                     *Minor*
                                                    Incorrect formulation                                                                                                                                                                                                                  --                                                                                                                                                                                                                                                                                                                                                     *Minor* unless formulation likely to have implication on treatment eg, Insulin, co-careldopa, in which case *significant/serious* based on potential consequence
                                                    No signature                                                                                                                                                                                                                           --                                                                                                                                                                                                                                                                                                                                                     *Significant* (governance issue)
                                                    Start date incorrect/missing                                                                                                                                                                                                           --                                                                                                                                                                                                                                                                                                                                                     *Minor*
                                                    CD requirements incorrect/missing                                                                                                                                                                                                      --                                                                                                                                                                                                                                                                                                                                                     *Minor*
  3\. Allergy status missing/significant allergy    Significant allergy                              Includes allergy status not completed, or where a drug has been prescribed despite an allergy to that drug/class                                                                      --                                                                                                                                                                                                                                                                                                                                                     *Significant* allergy status/specific allergy missed off prescription; *Serious* if patient prescribed agent allergic to; *Potentially lethal* if patient prescribed drug which previously had severe reaction to eg, oedema
  4\. Duration of treatment wrong/not specified     Continuation for longer than needed              Includes no stop/review date for antibiotics, steroids etc                                                                                                                            --                                                                                                                                                                                                                                                                                                                                                     *Minor* if continuation of the medicine or the duration represents little potential for harm; *Significant* if continued \>3 days longer than needed for medication such as: antibiotics, oral steroids, LMWH, potassium; *Serious* if ongoing treatment could cause serious harm
                                                    Premature discontinuation                        Includes drugs stopped without appropriate reducing course                                                                                                                            --                                                                                                                                                                                                                                                                                                                                                     *Minor* if discontinuation is unlikey to have a significant clinical impact; *Significant* if duration of treatment insufficient to treat condition eg, Antibiotics, or if no reducing course eg, oral steroids
  5\. Drug Interactions                             Drug interaction                                 Excludes 2 items prescribed from same class eg, omeprazole with lansporazole (duplication)                                                                                            *Serious* if drug orders could exacerbate a patient\'s condition eg, drug--drug interaction                                                                                                                                                                                                                                                            *Significant* if manufacturer advises the combination is contraindicated, should be avoided, or advises caution; *Serious* if adverse events highly probable
                                                    Drug interaction not taken into account          As above: unable to differentiate drug interaction and drug interaction not taken into account from available data                                                                                                                                                                                                                                                                                                                                                                                                                           
  6\. Omission of medication                        Omission on admission                                                                                                                                                                                                                  *Significant* (regular medication)                                                                                                                                                                                                                                                                                                                     --
                                                    Omission on discharge                                                                                                                                                                                                                  *Significant*                                                                                                                                                                                                                                                                                                                                          --
                                                    Drug not prescribed but indicated                                                                                                                                                                                                      --                                                                                                                                                                                                                                                                                                                                                     *Minor* if medication is unlikely to significantly impact patient care; *Significant* if medication would have significant impact on clinical course *Serious* if medication would alleviate a serious condition /patient is in acute distress; *Potentially lethal* if medication is potentially life saving
  7\. Excessive/ unnecessary prescribing            Duplication                                      Includes a second agent prescribed which contains an ingredient already being taken; 2 drugs prescribed from the same class/with same clinical effect eg, Lansoprazole + omeprazole   *Minor* if duplicate therapy prescribed without potential for increased adverse events                                                                                                                                                                                                                                                                 *Significant*, *Serious*, *Potentiallylethal*: As for overdose when duplicated items co-administered (3)
                                                    Unintentional prescription of drug               Drug prescribed was not that desired. Includes prescription of a discontinued drug, excluding discontinuation due to ADR, or course is too long                                       --                                                                                                                                                                                                                                                                                                                                                     Judgement used based on Equip severity categories
  8\. Clinical Safety Errors                        No maximum dose                                  Excludes prescriptions with no frequency (administration times missing/incorrect)                                                                                                     *Minor*- order lacked specific drug, dose, strength, frequency or route information                                                                                                                                                                                                                                                                    *Significant* if no maximum dose stated for opioids
                                                    Clinical contraindication                        Contraindication according to summary of product characteristics                                                                                                                      *Serious* if drug orders could exacerbate a patient\'s condition eg, Drug-disease interaction                                                                                                                                                                                                                                                          *Significant* if administration unlikely to have serious clinical consequences in the given situation
                                                    Continuation after ADR                                                                                                                                                                                                                 --                                                                                                                                                                                                                                                                                                                                                     Judgement used based on Equip severity categories
                                                    No dosage alteration after levels out of range                                                                                                                                                                                         --                                                                                                                                                                                                                                                                                                                                                     Judgement used based on Equip severity categories
  9\. Lack of clear directions for administration   Administration times incorrect/missing           No frequency/times of dosing incorrect eg, In relation to food, morning vs night                                                                                                      *Minor*                                                                                                                                                                                                                                                                                                                                                *Significant* if administration time would be expected to affect treatment eg, Exenatide with meals, hypnotics at night
                                                    Incorrect route                                                                                                                                                                                                                        *Minor* if unlikely to be carried out/little chance of toxicity/therapeutic failure; *Significant* if wrong route to treat condition; *Serious* if potential for toxicity                                                                                                                                                                              --
                                                    Intravenous instructions incorrect/missing                                                                                                                                                                                             --                                                                                                                                                                                                                                                                                                                                                     Judgement used based on Equip severity categories
                                                    Route missing                                                                                                                                                                                                                          *Minor*- order lacked specific drug, dose, strength, frequency or route information                                                                                                                                                                                                                                                                    --
                                                    Daily dose divided incorrectly                   Number of dosing intervals incorrect. Excludes under/overdose                                                                                                                         --                                                                                                                                                                                                                                                                                                                                                     *Minor* if dosing intervals are not standard, but are unlikely to significantly affect treatment; *Significant* if dosing intervals are inappropriate to treat the condition; *Serious* if medication has narrow TI and dosing intervals may affect toxicity/efficacy eg, parenteral aminoglycosides
  10\. Miscellaneous                                No indication                                    Includes PRN medications, where lack of indication on prescription could prevent administration. Excludes failure to write an indication when prescribing antibiotics                 --                                                                                                                                                                                                                                                                                                                                                     *Minor* if indication not written up for PRN medication; *Significant* if indication not written up for formulations which are licensed for specific conditions
                                                    Miscellaneous                                    Illegible drug details, non-standard abbreviations, patient details incorrect/missing, warfarin fixed dose prescribed                                                                 --                                                                                                                                                                                                                                                                                                                                                     Judgement used based on Equip severity categories

ADR,  adverse drug reaction; CD,  controlled drug; PRN- when required; TI,  therapeutic index.

Despite using a standard set of definitions, we noted discrepancies across various hospitals in both error categorisation and severity rating. In particular, there was a tendency to over-report errors and to overestimate their potential severity. This was confirmed by a post hoc inter-rater agreement analysis. A set of six sample prescriptions was generated. A list of 14 sample errors was decided by the study team, including study error type and severity, according to the criteria in [table 2](#BMJOPEN2012002036TB2){ref-type="table"} utilised for analysis of the main study. The errors selected occurred frequently in the main study, and covered a broad range of error categories and severities. Six pharmacists from each participating hospital were asked to each screen the six prescription scenarios containing the 14 errors and to record any observed errors, allocating error types and severities. The exact agreement percentages between category classification, severity classification and both combined were computed to measure the absolute concordances between pharmacist scores against the gold standard assessment.

In order to limit interobserver bias, all grading and severity of errors identified in the main study were independently reassessed by two members of the study team (KS and SK), with discordant assessments collectively discussed with a third (TK) in order to agree a final categorisation for error type and severity. For severity ratings, the summary of product characteristics for relevant medication was consulted, in order to determine potential implications of different degrees of overdose, underdose, of drug interactions and also to confirm clinical contra-indications.

Statistical analyses {#s2e}
--------------------

Data were analysed at the prescription level using complete case data. The prevalence and severity of errors observed were tabulated using percentage frequencies. A Forest plot was produced to present the error prevalence rate and 95% CI for each hospital and grade of the prescriber. For the formal statistical analysis, when there was more than one error on a prescription, only the most severe error was included. This approach was used to ensure that the errors included in the analysis were independent. In this study, we assessed hospital, prescriber grade (newly qualified, junior, mid-grade, senior, non-medical, other), ward area (medical, surgical, A&E, mental health, critical care), number of prescribed medicines, an indicator to denote whether the prescription was prescribed on admission or on discharge and an indicator to denote whether the prescriber was Liverpool trained or not as potential risk factors. Univariate statistical analyses were performed using a χ^2^ test except for continuous data, which were analysed using the Mann-Whitney U test. A multivariate logistic regression model for a prescription error was fitted to the data. Results are given in terms of an OR and associated 95% CI. All risk factors that were statistically significant (p\<0.1) in the univariate analysis were considered for inclusion in the multivariate model with the exception of ward area as a number of hospitals only reported a single specialty type.

All statistical analyses were carried out using the statistical software package SPSS (V.20) using a two-sided significance level of 0.05 (5%) throughout.

Results {#s3}
=======

Error classification {#s3a}
--------------------

During the post hoc inter-rater agreement analysis, approximately 75% of error categories were correctly identified by pharmacists when compared with the standards. Only 47% of severity ratings were concordant with the standards, and 40% of pharmacists rated both error category and severity in concordance with the standards.

Reassessment of errors by the study team resulted in exclusion of a total of 143 errors which were not considered true errors of the process of prescribing. The error category was regraded for 434 errors, and severity was regraded for 724 errors, which was predominantly a down-grading.

Descriptive data and severity of errors {#s3b}
---------------------------------------

A total of 4238 prescriptions were evaluated; of these, 1857 (43.8%) prescriptions contained at least one error ([table 3](#BMJOPEN2012002036TB3){ref-type="table"}). The overall prevalence of prescribing errors (number of prescriptions with one or more error/prescriptions evaluated) ranged from 20% to 60% across the nine hospitals ([figure 1](#BMJOPEN2012002036F1){ref-type="fig"}). The rate of errors per prescribed item was 10.9%.

###### 

Summary data showing prevalence and severity of errors observed

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------
                            Total prescriptions   One or more error reported   Error severity                                                                
  ------------------------- --------------------- ---------------------------- -------------------------- ------------- ------------- ----------- ---------- ------
  All                       4238                  2381 (56.2)                  1857 (43.8)                1264 (42.0)   1629 (54.1)   109 (3.6)   9 (0.3)    3011

  Prescriber Grade                                                                                                                                           

   Newly qualified          1805                  1087 (60.2)                  718 (39.8)                 519 (48.8)    507 (47.7)    35 (3.3)    3 (0.3)    1064

   Junior                   1484                  755 (50.9)                   729 (49.1)                 496 (39.2)    725 (57.4)    41 (3.2)    2 (0.2)    1264

   Mid-grade                366                   190 (51.9)                   176 (48.1)                 93 (33.6)     166 (59.9)    15 (5.4)    3 (1.1)    277

   Senior                   142                   96 (67.6)                    46 (32.4)                  36 (42.4)     43 (50.6)     6 (7.1)     0 (0)      85

   Non-medical              35                    26 (74.3)                    9 (25.7)                   8 (57.1)      5 (35.7)      1 (7.1)     0 (0)      14

   Unknown/other            406                   227 (55.9)                   179 (44.1)                 112 (36.5)    183 (59.6)    11 (3.6)    1 (0.3)    307

  Training                                                                                                                                                   

   Liverpool                1290                  787 (61.0)                   503 (39.0)                 270 (35.4)    456 (59.8)    36 (4.7)    1 (0.1)    763

   Non-Liverpool            922                   478 (51.8)                   444 (48.2)                 342 (43.8)    420 (53.8)    19 (2.4)    0 (0)      781

   Unknown                  2026                  1118 (55.2)                  908 (44.8)                 652 (44.4)    753 (51.3)    54 (3.7)    8 (0.5)    1467

  Admission/discharge                                                                                                                                        

   Discharge                2467                  1615 (65.5)                  852 (34.5)                 685 (52.5)    584 (44.8)    32 (2.5)    4 (0.3)    1305

   Admission                1744                  756 (43.4)                   988 (56.7)                 576 (34.2)    1030 (61.1)   75 (4.4)    5 (0.3)    1686

   Unknown                  27                    12 (44.44)                   15 (55.55)                 3 (15)        15 (75)       2 (10)      0 (0)      20

  Ward area                                                                                                                                                  

   Medicine                 2059                  1083 (52.6)                  976 (47.4)                 634 (39.0)    921 (56.7)    64 (3.9)    6 (0.37)   1625

   Surgery                  1395                  836 (59.9)                   559 (40.1)                 448 (50.1)    417 (46.6)    27 (3.0)    2 (0.2)    894

   Mental health            96                    66 (68.8)                    30 (31.3)                  24 (60)       16 (40)       0 (0)       0 (0)      40

   Accident and emergency   8                     1 (12.5)                     7 (87.5)                   1 (9.1)       10 90.9       0 (0)       0 (0)      11

   Critical care            17                    14 (82.4)                    3 (17.7)                   1 (25.0)      3 (75.0)      0 (0)       0 (0)      4

   Unknown                  663                   383 (57.8)                   280 (42.2)                 156 (35.7)    262 (60.0)    18 (4.1)    1 (0.2)    437

  Prescription contains†                                                                                                                                     

   Antibiotic               724                   301 (41.6)                   423 (58.4)\                57 (29.8)     118 (61.8)    16 (8.4)    0 (0)      191
                                                                               (Antibiotic: 130 (18.0))                                                      

   Insulin                  129                   42 (32.6)                    87 (67.4)\                 12 (37.5)     19 (59.4)     1 (3.1)     0 (0)      32
                                                                               Insulin: 20 (15.5)                                                            

   Warfarin                 196                   71 (36.2)                    125 (63.8)\                6 (23.1)      16 (61.5)     4 (15.4)    0 (0)      26
                                                                               Warfarin: 18 (9.2)                                                            

   Oxygen                   36                    7 (19.4)                     29 (80.6)\                 1 (14.3)      5 (71.4)      1 (14.3)    0 (0)      7
                                                                               Oxygen: 2 (5.6)                                                               
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------

†Error severities, total errors and error rates relate to errors associated with Antibiotics/Insulin/Warfarin/Oxygen only.

![Forest plot showing prescribing error rates in nine hospitals across North West England.](bmjopen2012002036f01){#BMJOPEN2012002036F1}

A total of 3011 individual errors were observed within the 1857 prescriptions containing an error. Of these 3011 errors, 1264 (41.9%) were minor, 1629 (54.1%) were significant, 109 (3.6%) were serious and nine (0.30%) were potentially life threatening ([table 3](#BMJOPEN2012002036TB3){ref-type="table"}). Details of all potentially life-threatening errors are listed in [table 4](#BMJOPEN2012002036TB4){ref-type="table"} and mainly comprised dosing errors (n=8), particularly overdose (n=7), with one incidence of underdose. A further error considered to be potentially lethal related to prescription of a medicine to which the patient had previously had a serious allergic reaction.

###### 

Summary of the errors observed which were considered to be potentially lethal

  Error description                                                                                                    Category                                         Prescriber grade   Ward area   Admission/discharge
  -------------------------------------------------------------------------------------------------------------------- ------------------------------------------------ ------------------ ----------- ---------------------
  Gliclazide 400 mg prescribed when 40 mg needed                                                                       1- Dosing errors                                 Newly qualified    Medicine    Discharge
  Digoxin 625 µg prescribed when 62.5 µg needed                                                                        1- Dosing errors                                 Newly qualified    Medicine    Discharge
  Oxycodone 500 mg prescribed: overdose                                                                                1- Dosing errors                                 Mid grade          Surgery     Admission
  Methotrexate prescribed daily, not weekly                                                                            1- Dosing errors                                 Junior             Medicine    Admission
  Doxazocin prescribed; had been stopped by general practitioner due to angioedema                                     3\. Allergy status missing/significant allergy   Junior             Medicine    Admission
  Phenytoin dose of 300 mg daily incorrectly prescribed as 800 mg                                                      1- Dosing errors                                 Newly qualified    Medicine    Discharge
  Midazolam intravenous for sedation: overdose                                                                         1- Dosing errors                                 Mid grade          Unknown     Admission
  Amiodarone loading dose of 200 mg three times daily continued as a regular dose                                      1- Dosing errors                                 Other              Surgery     Discharge
  Enoxaparin prescribed 1 mg/kg once daily instead of 1 mg/kg twice daily for a patient with acute coronary syndrome   1- Dosing errors                                 Mid grade          Medicine    Admission

The proportion of errors categorised with severity as significant or higher by prescriber grade were as follows: all prescribers 58.0%, newly qualified 51.2%, junior 60.8%, mid grade 66.4%, senior 57.6% (χ^2^~trend~ p\<0.001 for univariate analysis, although this association disappeared when corrected for other potential confounders; [table 3](#BMJOPEN2012002036TB3){ref-type="table"}).

Fewer errors were observed on discharge prescriptions than on prescriptions written on admission. More errors were observed in prescriptions containing antibiotics, insulin, warfarin and oxygen, although this does not take into account the number of items on each prescription. Whether doctors were Liverpool trained or not did not affect the number of errors observed ([table 3](#BMJOPEN2012002036TB3){ref-type="table"}).

Differences in error prevalence and error types were observed in individual participating hospitals. The lowest rates of errors were reported for the paediatrics specialty hospital, with 0.07 errors observed per prescribed item, and 0.26 errors observed per prescription. However, in multivariate analysis, there was no significant reduction in error risk and it is likely that the effect could be due to lower number of items per prescription (mean 3.5, vs pooled data: 6.3). The most common error types were dosing errors (30%) and medication omission (23.1%).

Significantly lower risk of errors was observed in the hospital providing specialist services for women (p=0.04, [table 5](#BMJOPEN2012002036TB5){ref-type="table"}) in multivariate analysis. One of the lowest error rates per prescription was observed (0.28), although the error rate per prescribed item (0.11) was equal to that of the pooled data. The most common error type observed was excessive/unnecessary prescribing (50%). No errors of medication omission were observed. This hospital also had a low number of items per prescription (2.4), and was using electronic prescribing systems on some wards.

###### 

Multivariate logistic regression analysis for predicting error rates in prescriptions

  Variable                     OR (95% CI)           p Value
  ---------------------------- --------------------- ---------
  Hospital                                           
   Hospital H                  1                     
   Hospital A                  Not estimable\*       
   Hospital B                  1.11 (0.78 to 1.58)   0.57
   Hospital C                  2.38 (1.63 to 3.46)   \<0.001
   Hospital D                  0.64 (0.13 to 3.06)   0.57
   Hospital E                  1.39 (0.96 to 2.01)   0.08
   Hospital F                  3.53 (2.63 to 4.73)   \<0.001
   Hospital G                  1.80 (1.03 to 3.12)   0.04
   Hospital I                  1.11 (0.73 to 1.70)   0.62
  Prescriber grade                                   
   Newly qualified             1                     
   Junior                      1.06 (0.85 to 1.32)   0.61
   Mid-grade                   0.96 (0.64 to 1.44)   0.83
   Senior                      0.97 (0.58 to 1.63)   0.92
   Non-medical                 0.59 (0.21 to 1.64)   0.31
   Other                       1.50 (0.53 to 4.23)   0.44
  Discharge/admission          1.16 (0.70 to 1.92)   0.58
  Number of prescribed items   1.14 (1.12 to 1.17)   \<0.001

Analysis contains only 2127 records (50.2%) where complete data was provided for all variables.

\*Trust provided no data on number of prescription items.

Error types {#s3c}
-----------

The most frequent error types for all prescribers were medication omission, accounting for 26.9%, writing errors accounting for (20.7%) and dosing errors accounting for (20.6%) of all errors recorded. There was little difference in the variability of error types across different prescriber grades ([figure 2](#BMJOPEN2012002036F2){ref-type="fig"}).[](#BMJOPEN2012002036F3){ref-type="fig"}

![Categories of prescribing errors made by different grades of prescriber.](bmjopen2012002036f02){#BMJOPEN2012002036F2}

![Forest plot showing prescribing error rates made by different prescriber grades.](bmjopen2012002036f03){#BMJOPEN2012002036F3}

Risk factor analysis {#s3d}
--------------------

Results of the univariate analysis are shown in [table 6](#BMJOPEN2012002036TB6){ref-type="table"}. Missing data limited inclusion of all reported prescriptions in risk factor analysis, notably as one acute hospital failed to return data on number of items on each prescription. All factors considered appeared to show a significant difference except for whether doctors had trained in Liverpool, which made no significant difference (p=0.91) to whether an error occurred on the prescription. Multivariate risk factor analysis showed that the likelihood of an error increased for every additional item included on the prescription (OR 1.14, 95% CI 1.12 to 1.17, p\<0.001; [table 6](#BMJOPEN2012002036TB6){ref-type="table"}). Therefore, for each additional item on the prescription, the risk of an error occurring increased by about 14%. There was also a trend towards errors being more likely to occur on admission prescriptions than on discharge prescriptions, with an OR of 1.16 (95% CI 0.70 to 1.92, p=0.58), although this difference did not reach statistical significance ([table 5](#BMJOPEN2012002036TB5){ref-type="table"}). No significant differences were found in error rates between different prescriber grades, when compared with newly qualified doctors ([figures 2](#BMJOPEN2012002036F2){ref-type="fig"} and [3](#BMJOPEN2012002036F3){ref-type="fig"}) in multivariate analyses.

###### 

Univariate statistics showing the significance of explanatory variables in predicting error rates in prescriptions

                                                                     ≥1 Error             No error                                    
  ----------------------------------------------------------- ------ -------------------- ------------------- ----------------------- ---------
  Prescriber grade (n=3850)                                          1689                 2161                                        
   Newly qualified                                            1803   716 (42)             1087 (50)           −8 (−11.2 to −4.8)      \<0.001
   Junior                                                     1482   727 (43)             755 (35)            8 (4.9 to 11.1)         
   Mid-grade                                                  366    176 (10)             190 (8.8)           1.2 (−0.7 to 3.1)       
   Senior                                                     142    46 (2.7)             96 (4.4)            −1.7 (−2.8 to −0.4)     
   Non-medical                                                35     9 (0.5)              26 (1.2)            −0.7 (−1.3 to −0.1)     
   Other                                                      22     15 (0.9)             7 (0.3)             0.56 (0.1 to 1.1)       
  Discharge/admission (n=3065)                                       1135                 1930                                        
   Discharge                                                  2467   853 (75)             1614 (84)           −9 (−12.0 to −6.0)      \<0.001
   Admission                                                  598    282 (25)             316 (16)                                    
  Liverpool trained (n=1325)                                         518                  807                                         
   Liverpool                                                  35     14 (2.7)             21 (2.6)            0.1 (−1.7 to 1.9)       0.911
   Non-Liverpool                                              1290   504 (97)             786 (97)                                    
  Hospital (n=4238)                                                  1857                 2381                                        
   Hospital A                                                 762    366 (20)             396 (17)            3 (0.6 to 5.4)          \<0.001
   Hospital B                                                 513    239 (12)             274 (12)            0 (−2.0 to 2.0)         
   Hospital C                                                 500    296 (16)             204 (8.6)           7.4 (5.4 to 9.4)        
   Hospital D                                                 97     30 (1.6)             67 (2.8)            −1.2 (−2.1 to −0.3)     
   Hospital E                                                 371    160 (8.6)            211 (8.9)           −0.3 (−2.0 to 1.4)      
   Hospital F                                                 604    355 (19)             249 (10)            9 (6.8 to 11.2)         
   Hospital G                                                 86     22 (1.2)             64 (2.7)            −1.5 (−2.3 to −0.7)     
   Hospital H                                                 807    290 (16)             517 (22)            −6 (−8.4 to −3.6)       
   Hospital I                                                 498    99 (5.3)             399 (17)            −11.7 (−13.5 to −9.9)   
  Ward area (n=3575)                                                 1577                 1998                                        
   Medical                                                    2059   977 (62)             1082 (54)           8 (4.8 to 11.2)         \<0.001
   Surgical                                                   1395   560 (36)             835 (42)            −6 (−9.2 to −2.8)       
   Accident *&* emergency                                     8      7 (0.4)              1 (0.1)             0.3 (−0.04 to 0.6)      
   Mental health                                              96     30 (1.9)             66 (3.3)            −1.4 (−2.4 to −0.4)     
   Critical care                                              17     3 (0.2)              14 (0.7)            −0.5 (−0.9 to −0.1)     
  Number of medicines on prescription (n=3386) Median (IQR)          8; (4,11) (n=1435)   4; (2,7) (n=1951)   −4 (−4.5 to −3.5)       \<0.001

n, number of prescriptions.

Discussion {#s4}
==========

In this large study, only 56.2% of 4238 prescriptions written had no reported errors. Of the errors recorded, 41.9% were minor, 54.1% significant, 3.6% serious and 0.3% potentially life threatening. It is important to note that severity ratings relate to the potential severity had the error been allowed to progress through to the patient---in fact the majority of errors were corrected prior to the point of administration. In multivariate analysis, the strongest predictor for prescribing error was the number of medicines on each prescription, with risk for prescribing error increasing by 14% for every additional medication item prescribed. Where data were available, prescriptions contained an average of 6.3 medication items, although this varied from 2.4 to 7.5 items according to medical specialty surveyed. Uncorrected analyses suggested that errors were frequent in prescriptions containing insulin (15.5%), antibiotics (18%), warfarin (9.2%) and oxygen (5.6%), although these patients were very likely to have been receiving multiple medications. Error rates were highest among specialties which prescribed a broad range of medications (eg, acute medicine, compared with elective surgery), and also differed between different hospital Trusts, with hospitals specialising in paediatrics, maternal health and mental health exhibiting the lowest error rates. However, when corrected for number of medications, these differences did not remain significant, with the exception of maternal health.

The most frequent error encountered was unintended medication omission following acute hospital admission (0.97 errors/prescription written, vs 0.53 for discharge medications).

When adjusted in multivariable analyses ([table 5](#BMJOPEN2012002036TB5){ref-type="table"}) there was no statistically significant difference in error rates between admission and discharge. We found no overall difference in error rate among different grades of prescriber, and newly qualified doctors were not more likely to make errors than their senior colleagues. Although numbers were relatively small, we observed no difference in error rate among newly qualified doctors by undergraduate training, and doctors trained in Liverpool were neither more nor less likely to commit medication errors. The categories and severity of errors made by different prescriber grades were broadly similar (table 3; [figure 2](#BMJOPEN2012002036F2){ref-type="fig"}); however, some differences were observed. For example, writing errors were more frequently observed with newly qualified doctors, medication omission was more frequently observed with junior and mid-grade doctors, and dosing errors were more frequently observed with mid-grade doctors.

These results are consistent with previously published studies. Both the EQUIP and PRACtICe Studies[@R3] [@R6] reported error rates of approximately 1 in 10 medications prescribed (we observed a rate of 10.9%). Given the high number of medications prescribed (mean of 6.3 items/prescription) nearly half of all prescriptions contained at least one error.

A systematic review found prescribing errors to be more common in adults than in children.[@R1] A study in Spain comparing paediatric wards with obstetrics found that paediatric patients had a fourfold higher risk of serious errors than the maternity population (2.3% vs 14.3%), which were mainly related to drug dosing.[@R21] We observed a low error rate for the paediatrics specialty hospital, although this was likely due to a low number of prescribed items. Dosing errors were the most common error type. Another study reported that prescribing errors were more common in primary care among men compared with women.[@R6] We observed a significantly lower risk for errors in specialist services for women.

In the EQUIP study, multivariate analysis showed that all grades of doctors were more likely to write a prescription containing an error than consultants.[@R3] A retrospective study which evaluated errors on discharge prescriptions found no significant difference in error rates between prescriber grades, although no senior (consultant) level prescribers were included.[@R14] In primary care, the grade of general practitioner was not associated with prescribing errors.[@R6] We observed no significant difference in prescribing error rates between prescriber grades, when compared with newly qualified prescribers. EQUIP also reported that medication orders issued at acute admission were 70% more likely to be associated with a prescribing error.[@R3] Another study found lower error rates on discharge prescription items than was observed with general inpatient prescribing, due to a lower rate of medication omission, however these factors were not corrected for the number of items on each prescription.[@R2] We observed a trend towards errors being more likely to occur on admission prescriptions than on discharge prescriptions, with an OR of 1.16, although this did not reach significance in multivariate analysis.

In multivariate analysis, the strongest predictor for prescribing error was the number of medicines on each prescription, with risk for prescribing error increasing by 14% for every additional medication item prescribed. Complex polypharmacy is becoming increasingly common, with patients potentially requiring management for multiple chronic conditions simultaneously. In these patients, vigilance for prescribing errors and pharmacist review is of particular importance.

Our study was limited by missing data (one acute hospital failed to return data on number of items on each prescription), and although pharmacists had received some basic training in completing the evaluations, post hoc analyses suggested significant variability between pharmacists' classification of errors, and especially in assignment of severity classification. Two of us independently revised each prescribing error and noted a tendency to overestimate the severity of errors, and (in keeping with EQUIP criteria) included in our evaluations an assessment of whether or not a wrong dose was likely to have been actually administered based on tablet burden. We also refined EQUIP criteria to assign severity ratings to error categories where these had previously not been provided. Finally, in order to limit the impact of error misclassification on study findings, the original 29 error categories were batched into 10 different types of error groups relating to key components of prescribing. Since our data collection forms did not allow us to evaluate errors which had been missed, it is possible that our observed error rates may represent an underestimate of the true burden of prescribing error.

Medication omission was the most prevalent error, representing 26.9% of all errors observed, which is consistent with previous reports.[@R2] [@R14] Prescribing during acute admission in the absence of a full medication history may sometimes be unavoidable, and does not necessarily constitute an error. For this reason, we discriminated between 'emergency' prescribing, and errors where a more complete or accurate medication history would have prevented omission of prescribed medications. Although we sought to capture only unintended medication omission, it is possible that there might still have been cases where the omission was intentional (eg, suspension of diuretics in a patient who was hypotensive or dehydrated on admission) but this intent had been missed by the pharmacist collecting the data. A sensitivity analysis showed that if all errors of medication omission either on discharge or admission were excluded, the number of errors totals 2249 (0.53 per prescription written); with 1471 (34.7%) prescriptions containing at least one error, which represents a significant reduction in overall prescribing error rate. A core role for clinical ward based pharmacists is medicines reconciliation for admitted patients. This involves detailed medication history taking, recording of full medication list in the patient\'s case notes, and discussion with the clinical team to ensure that all regular medicines are prescribed throughout the admission, if appropriate. Similarly, on discharge, pharmacists ensure that necessary regular medicines are continued, and that any medicines newly started during the admission are prescribed for discharge as appropriate. The majority of the omission errors reported will have been rectified during admission or prior to discharge, as a result of the pharmacist clinical check. This highlights the importance of medicines reconciliation as soon as practicable at hospital admission, in order to minimise the possibility of missed doses of essential medicines. The role of pharmacists in acute admission settings may therefore be of particular benefit.

EQUIP error categories which could potentially be eliminated by the introduction of electronic prescribing (strength/dose missing, product/formulation not specified, no signature, start date incorrect/missing, incorrect route, intravenous instructions incorrect/missing) accounted for 357 (11.9%) of the 3011 errors observed. A further 376 (12.5%) errors could be reduced by electronic prescribing, via alerts, cautions and required fields at the patient entry/prescribing stage, although many of these can be over-ridden by the prescriber.[@R22] These include: administration times missing/incorrect, duplication, CD requirements incorrect/missing. The extent to which electronic prescribing can eliminate particular error types depends on the individual systems used. Importantly, while electronic prescribing systems could potentially have prevented up to a quarter of errors, these systems are best utilised alongside rather than instead of existing safeguards. We did not formally evaluate differences in error rates between electronic prescribing and paper-based prescribing systems. Although one hospital (Hospital G) was utilising complete electronic prescribing systems on some wards at the time of the study, and many of the other hospitals were using electronically generated discharge summaries, we failed to observe any clear association with error rate, mainly because of the large variability in case mix which impacted directly on the number of items/prescription. In contrast, EQUIP reported that electronic prescriptions were 12% less likely to be associated with a prescribing error than handwritten prescriptions.[@R3] Although electronic discharge summaries may reduce error due to legibility, they do not eliminate the transcription step from inpatient charts. One study which analysed 1808 handwritten and electronic discharge summaries found no difference in the number or types of errors observed.[@R14] It is also worth noting that electronic systems, while clearly offering an advantage over conventional medicines management and prescribing systems, have themselves been associated with new patterns of error. Studies in the UK and Australia found a significant reduction in prescribing errors detected after introduction of electronic prescribing systems, but also identified errors specific to the electronic prescribing system used, for example, incorrect product selected from drop-down menu, or incorrect dosing frequency selected.[@R23; @R24; @R25] These electronic systems will doubtlessly continue to improve through refinement.[@R22] [@R26]

The Erice Medication Errors Research Group recommendations for reducing prescribing errors, includes training and assessment of prescribers, ongoing monitoring, awareness and communication.[@R13] Health systems which may impact on likelihood of error occurring include European harmonisation of prescribing, introduction of integrated prescription forms, use of IT systems such as electronic prescribing, and standardisation, evaluation and certification of such systems. Involvement of clinical pharmacists at all points of the medication process is also recommended.[@R13] The latter is important since all the hospital Trusts in our survey had evolved systems to safeguard patients from prescribing error (regardless of the adoption of electronic prescribing), and this involved use of ward-based pharmacists and dispensary staff to perform routine checks on all prescriptions issued[@R3] [@R9] [@R21] [@R27] This likely represents the 'last line of defence' against prescribing error, and has greatest utility when deployed in clinical areas associated with highest risk, for example patients with complex polypharmacy, and hospital admission settings. One fundamental role of clinical pharmacists during acute admission is medicines reconciliation, where a patient\'s full medication history is determined and recorded using all available sources of information. We found that prescribing errors in secondary care are prevalent, regardless of prescriber grade. Our findings therefore suggest that removing this safeguard (eg, through service reconfiguration or in an effort to reduce costs) could potentially lead to higher numbers of medication errors actually reaching the patient.
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